Robert Mashal - 09 Jun 2026 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Reporting relationship
Director
Issuer ticker
NUVB
Reported as of
09 Jun 2026
Net transaction value
+$118,250
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Jun 2026, 20:02:51 UTC
Prior SEC filing
26 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen Dang, Attorney-in-Fact

Key filing fact

Robert Mashal filed Form 4 for Nuvation Bio Inc. (NUVB) on 11 Jun 2026.

Key facts

  • This page summarizes Robert Mashal's Form 4 filing for Nuvation Bio Inc. (NUVB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Jun 2026, 20:02.

Change

  • Previous filing in this sequence was filed on 26 May 2026.
  • Current net transaction value: +$118,250.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002007102 Primary reporting owner

Mashal Robert

Relationship
Director
Address
C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK
Signature
/s/ Stephen Dang, Attorney-in-Fact
Signature date
11 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Purchase

Transaction value
$118,250
Shares
+25,000
Change %
+12%
Price
$4.73
Shares after
225,000
Date
09 Jun 2026
Ownership
By Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .